ResearcherUniversity of Hong KongNo recent work listed
Oscar Hou In Chou
Matched on ORCID iD 0000-0001-7058-4708; OpenAlex author ID A5018557223. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2022: 2 papers
Papers 2
- Lower risks of new-onset acute pancreatitis and pancreatic cancer in sodium glucose cotransporter 2 (SGLT2) inhibitors compared to dipeptidyl peptidase-4 (DPP4… Co-author DOI 10.1016/j.deman.2022.100115↗
- Risk Factors of Pancreatic Cancer in Patients With Type 2 Diabetes Mellitus: The Hong Kong Diabetes Study. Co-author DOI 10.1210/jendso/bvac138↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Gary Tse · 2 shared papers, 2022 · strength 0.28
- Paper Lower risks of new-onset acute pancreatitis and pancreatic cancer in sodium glucose cotransporter 2 (SGLT2) inhibitors … DOI 10.1016/j.deman.2022.100115↗
- Paper Risk Factors of Pancreatic Cancer in Patients With Type 2 Diabetes Mellitus: The Hong Kong Diabetes Study. DOI 10.1210/jendso/bvac138↗
- Edward Christopher Dee · 2 shared papers, 2022 · strength 0.28
- Paper Lower risks of new-onset acute pancreatitis and pancreatic cancer in sodium glucose cotransporter 2 (SGLT2) inhibitors … DOI 10.1016/j.deman.2022.100115↗
- Paper Risk Factors of Pancreatic Cancer in Patients With Type 2 Diabetes Mellitus: The Hong Kong Diabetes Study. DOI 10.1210/jendso/bvac138↗
- Sharen Lee · 2 shared papers, 2022 · strength 0.28
- Paper Lower risks of new-onset acute pancreatitis and pancreatic cancer in sodium glucose cotransporter 2 (SGLT2) inhibitors … DOI 10.1016/j.deman.2022.100115↗
- Paper Risk Factors of Pancreatic Cancer in Patients With Type 2 Diabetes Mellitus: The Hong Kong Diabetes Study. DOI 10.1210/jendso/bvac138↗
- Bernard M.Y. Cheung · 1 shared paper, 2022 · strength 0.14
- Raymond Ngai Chiu Chan · 1 shared paper, 2022 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.